Overview
Eugene Hsu practices practicing medicine in Darlinghurst, Australia.
His clinical expertise encompasses Malignant Peripheral Nerve Sheath Tumor, Neurofibromatosis Type 2 (NF2), and Fibrosarcoma.
He is actively involved in clinical research, co-authoring 10 peer reviewed articles.
Gender
Locations
Darlinghurst, NSW, Australia
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Eugene Hsu
Is Eugene Hsu a top-rated expert for Malignant Peripheral Nerve Sheath Tumor?
MediFind is an objective health platform that identifies experts based on real-world data. Eugene Hsu is classified as an Experienced expert for Malignant Peripheral Nerve Sheath Tumor, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Eugene Hsu participate in research or clinical trials?
Yes. Eugene Hsu has published 10 articles and abstracts on conditions like Malignant Peripheral Nerve Sheath Tumor. You can view a list of Eugene Hsu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- FibrosarcomaMr. Hsu isExperienced. Learn about Fibrosarcoma.
- Malignant Peripheral Nerve Sheath Tumor
- Neurofibromatosis Type 2 (NF2)Mr. Hsu isExperienced. Learn about Neurofibromatosis Type 2 (NF2).